All In Biotech

Drug Trial Radar · NCT06776432

Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

A Phase 2A Double-Blind Randomized, Controlled, Dose Escalation, Parallel- Arm, Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

60

Actual

Start

Apr 2, 2025

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
ShionogiIndustry
Sponsor type
Industry
First posted
Jan 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a central component.

Conditions

  • Sleep Apnea

Interventions

  • SivopixantDrug

    Administered as specified in the treatment arm

  • PlaceboDrug

    Administered as specified in the treatment arm.

  • AcetazolamideDrug

    Administered as specified in the treatment arm

  • SASS-001Drug

    Administered as specified in the treatment arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Endpoint - Change in apnea-hypopnea index (SASS-001 arm vs baseline at Visit 7 polysomnography). Scale is minimum -60 to max 60. Lower scores mean improvement from baseline.Time frame: up to 6 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Altman Clinical and Translational Research Institute (ACTRI)

    La Jolla, California

  • Teradan Clinical Trials

    Brandon, Florida

  • PharmaDev Clinical Research Institute, LLC

    Miami, Florida

  • Infinity Medical Research

    North Dartmouth, Massachusetts

  • John D. Dingell VA Medical Center

    Detroit, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • Intrepid Research, LLC

    Cincinnati, Ohio

  • OnSite Clinical Solutions

    Rock Hill, South Carolina

  • Huntsville Research Institute LLC

    Huntsville, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.